Docetaxel Injection 20 mg

About Docetaxel Injection 20 mg

Docetaxel Injection 20 mg Uses

• Treats metastatic breast cancer
• Used in non small cell lung cancer
• Part of chemotherapy regimens for prostate cancer
• Suitable for smaller dose adjustments based on body surface area

Docetaxel Injection 20 mg Benefits

• Allows precise low dose or reduced cycle dosing when needed
• Useful for dose reduction after side effects in earlier cycles
• Effective across multiple solid tumor types
• Administered under close hospital supervision for safety

Docetaxel Injection 20 mg Drug Class

• Taxane class antineoplastic agent
• Microtubule inhibitor chemotherapy drug

What Experts Say

Docetaxel binds to microtubules inside cancer cells and prevents them from breaking down normally during cell division, which stops tumor cells from multiplying further. The 20mg vial size is particularly useful for smaller patients or for planned dose reductions after a previous cycle caused significant side effects.

Oncologists calculate the exact required dose using body surface area, and keeping a smaller vial size available allows the correct amount to be prepared accurately without excessive drug wastage for lower dose patients. Full blood counts are checked before every infusion to confirm it remains safe to proceed with the next cycle.

Because specialized chemotherapy access is often centered in a handful of major hospitals across Pakistan, patients frequently travel long distances from smaller towns for each treatment cycle. Having both smaller and larger vial sizes available helps hospital oncology pharmacies prepare accurate, patient specific doses efficiently, reducing both cost and unnecessary drug wastage.

Docetaxel Injection 20 mg formula

• Docetaxel

Available forms

• Injection

How to use Docetaxel Injection 20 mg?

• Administered only as a slow intravenous infusion by trained medical staff
• Given in a hospital or oncology day care setting
• Premedication with corticosteroids is usually required before infusion
• Dosing interval and cycle length are set by the treating oncologist
• Blood counts are checked before each cycle

Drug Interactions

• Ketoconazole and Azole Antifungals: Strong CYP3A4 inhibitors that raise Docetaxel blood levels
• HIV Protease Inhibitors: Can significantly increase drug exposure and toxicity risk
• Macrolide Antibiotics: Erythromycin and similar drugs may increase side effects
• Other Chemotherapy Drugs: Combined regimens require dose adjustment and closer monitoring
• Live Vaccines: Should be avoided during chemotherapy due to weakened immunity

Risks and warnings

• Neutropenia: Severe drop in white blood cells is common and increases infection risk
• Hypersensitivity Reactions: Severe allergic reactions can occur despite premedication
• Fluid Retention: Can cause swelling and fluid buildup around the lungs
• Liver Impairment: Higher risk of severe toxicity in patients with abnormal liver function
• Pregnancy: Can cause serious harm to an unborn baby, contraception advised during treatment

Docetaxel Injection 20 mg Side Effects

• Hair loss
• Low blood cell counts
• Nausea and vomiting
• Fatigue and weakness
• Nerve tingling or numbness in hands and feet
• Mouth sores
• Skin and nail changes
• Fluid retention and swelling

Storage Conditions

• Store the unopened vial in a refrigerator between 2°C and 8°C
• Protect from light by keeping the vial in its original carton
• Do not freeze the vial
• Use the diluted infusion solution promptly as directed by hospital pharmacy protocol
• Handle and dispose of as a cytotoxic drug according to hospital safety guidelines